Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anthony Tumber

Showing results (31-40 of 106) with videos related to

Pageof 11
Sort By:
RSC Chemical Biology|March 13, 2023
Substrate selectivity and inhibition of histidine JmjC hydroxylases MINA53 and NO66Vildan A Türkmen, Jordi C J Hintzen, Anthony Tumber, et al.
Protein Science : a Publication of the Protein Society|September 14, 2024
Substrate selectivity and inhibition of the human lysyl hydroxylase JMJD7Nurgül Bilgin, Anthony Tumber, Siddhant Dhingra, et al.
Medchemcomm|May 7, 2019
Studies on spiro[4.5]decanone prolyl hydroxylase domain inhibitorsJames P Holt-Martyn, Anthony Tumber, Mohammed Z Rahman, et al.
Chemical Communications (Cambridge, England)|August 6, 2019
Targeting the Mycobacterium tuberculosis transpeptidase Ldt<sub>Mt2</sub> with cysteine-reactive inhibitors including ebselenMariska de Munnik, Christopher T Lohans, Pauline A Lang, et al.
Chemmedchem|December 1, 2021
Structure-Activity Studies Reveal Scope for Optimisation of Ebselen-Type Inhibition of SARS-CoV-2 Main ProteaseSiegfried T D Thun-Hohenstein, Timothy F Suits, Tika R Malla, et al.
Journal of Medicinal Chemistry|September 22, 2022
Development and Characterization of Type I, Type II, and Type III LIM-Kinase Chemical ProbesThomas Hanke, Sebastian Mathea, Julia Woortman, et al.
The Biochemical Journal|October 26, 2019
Lessons from LIMK1 enzymology and their impact on inhibitor designEidarus Salah, Deep Chatterjee, Alessandra Beltrami, et al.
Journal of Medicinal Chemistry|April 23, 2025
Derivatives of the Clinically Used HIF Prolyl Hydroxylase Inhibitor Desidustat Are Efficient Inhibitors of Human γ-Butyrobetaine HydroxylaseThomas P Corner, Anthony Tumber, Eidarus Salah, et al.
Chemical Communications (Cambridge, England)|November 20, 2018
Small-molecules that covalently react with a human prolyl hydroxylase - towards activity modulation and substrate captureJacob T Bush, Robert K Leśniak, Tzu-Lan Yeh, et al.
Cancer Chemotherapy and Pharmacology|November 25, 2006
The histone deacetylase inhibitor PXD101 synergises with 5-fluorouracil to inhibit colon cancer cell growth in vitro and in vivoAnthony Tumber, Laura S Collins, Kamille Dumong Petersen, et al.
Pageof 11

Showing results (31-40 of 106) with videos related to

Sort By:
Pageof 11
RSC Chemical Biology|March 13, 2023
Substrate selectivity and inhibition of histidine JmjC hydroxylases MINA53 and NO66Vildan A Türkmen, Jordi C J Hintzen, Anthony Tumber, et al.
Protein Science : a Publication of the Protein Society|September 14, 2024
Substrate selectivity and inhibition of the human lysyl hydroxylase JMJD7Nurgül Bilgin, Anthony Tumber, Siddhant Dhingra, et al.
Medchemcomm|May 7, 2019
Studies on spiro[4.5]decanone prolyl hydroxylase domain inhibitorsJames P Holt-Martyn, Anthony Tumber, Mohammed Z Rahman, et al.
Chemical Communications (Cambridge, England)|August 6, 2019
Targeting the Mycobacterium tuberculosis transpeptidase Ldt<sub>Mt2</sub> with cysteine-reactive inhibitors including ebselenMariska de Munnik, Christopher T Lohans, Pauline A Lang, et al.
Chemmedchem|December 1, 2021
Structure-Activity Studies Reveal Scope for Optimisation of Ebselen-Type Inhibition of SARS-CoV-2 Main ProteaseSiegfried T D Thun-Hohenstein, Timothy F Suits, Tika R Malla, et al.
Journal of Medicinal Chemistry|September 22, 2022
Development and Characterization of Type I, Type II, and Type III LIM-Kinase Chemical ProbesThomas Hanke, Sebastian Mathea, Julia Woortman, et al.
The Biochemical Journal|October 26, 2019
Lessons from LIMK1 enzymology and their impact on inhibitor designEidarus Salah, Deep Chatterjee, Alessandra Beltrami, et al.
Journal of Medicinal Chemistry|April 23, 2025
Derivatives of the Clinically Used HIF Prolyl Hydroxylase Inhibitor Desidustat Are Efficient Inhibitors of Human γ-Butyrobetaine HydroxylaseThomas P Corner, Anthony Tumber, Eidarus Salah, et al.
Chemical Communications (Cambridge, England)|November 20, 2018
Small-molecules that covalently react with a human prolyl hydroxylase - towards activity modulation and substrate captureJacob T Bush, Robert K Leśniak, Tzu-Lan Yeh, et al.
Cancer Chemotherapy and Pharmacology|November 25, 2006
The histone deacetylase inhibitor PXD101 synergises with 5-fluorouracil to inhibit colon cancer cell growth in vitro and in vivoAnthony Tumber, Laura S Collins, Kamille Dumong Petersen, et al.
Pageof 11